Belgian CDMO Ardena expands bioanalytical services in the Netherlands for drug development.

Ardena, a Belgian CDMO, is expanding its bioanalytical services in the Netherlands to meet the rising demand in the pharmaceutical and biotechnology industries. This includes a new lab at its Pivot Park in Oss, operational by Q1 2025, and enhanced capabilities at its Assen facility. The expansions will support clients at all stages of drug development, following Ardena's recent acquisition of a U.S. manufacturing facility from Catalent.

October 29, 2024
5 Articles